Prostate Cancer

Both companies were self-financing at the end of the year under review, which is why the board of directors assumed that the costs are a one-off sum for restructuring which is not shown in the adjusted profit or loss.

Without the adjustment the profit or loss for the group in 2005 before tax was 2.2 million EUR, the net income was 1.6 million EURO (0.51 EUR per share).

The board of directors will propose a dividend of 0.15 EUR per share at the shareholders’ meeting on 30 May.

In the previous year the comparable values for the group profit or loss before tax was 3.2 million EUR and the net income was 3.3 million EUR (1.09 EUR per share).

As a result of the special effects from the discontinued business units from the de-consolidation the profit or loss of both years are only partly comparable.

The dividend last year amounted to 0.25 EUR per share.

Approximately half the growth in turnover of 6.3 million EUR in 2005 was put down to organic growth, the rest came from the acquisition of four new companies.

In addition to the...

Read more...